Time Finance Strengthens NatWest Partnership with £65M Funding Boost for UK Businesses

TIME

Time Finance plc (LON:TIME), the AIM-listed independent specialist finance provider, has announced the renewal and expansion of its invoice finance funding facility with NatWest. The facility has been increased to £65 million, with £55 million fully committed and an additional £10 million available through an accordion feature. This capital will be dedicated to funding UK businesses through the company’s growing invoice finance division, Time Invoice Finance (TIF).

The expanded facility reflects Time Finance’s robust growth trajectory. Since launching its four-year strategic plan in June 2021, TIF has seen significant demand, with funds advanced to clients rising by over 170% to £68 million by the end of August 2024. This facility will help meet the increasing needs of SMEs seeking dependable financing solutions.

Financially, Time Finance is well-positioned for future growth. With a market capitalisation of £56.2 million and an enterprise value of £55.3 million, the company’s liquidity remains healthy, with cash reserves of £1.59 million and net debt standing at £0.28 million. The company is capitalising on strong momentum, showing a 23.0% sales growth for FY 2024, reaching £33.2 million in revenue. Operating profit also saw a significant increase, up 41.7% to £6 million.

The stock currently trades at 60.8p, near the top end of its 52-week range of 26.6p to 63.8p, with a daily trading volume of 88.5k shares. With 92.5 million shares in circulation, Time Finance maintains daily liquidity at 0.10%. The latest historical price-to-earnings ratio is 12.65, reflecting its solid performance metrics.

In related news, both CFO James Roberts and Non-Executive Chair Tanya Raynes have increased their shareholdings in the company, with Roberts acquiring 16,675 ordinary shares at a price of 59.85p and Raynes purchasing 4,939 shares at 60.73p. Additionally, the company has confirmed the vesting of 611,666 share options under its 2022 Unapproved Share Option Scheme, tied to profit-based performance criteria.

Time Finance provides a range of funding solutions, including invoice finance, asset finance, and loans, catering to the needs of SMEs across the UK.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Time Finance adds experienced Relationship Manager as Invoice Finance team expands

Time Finance has expanded its Invoice Finance operations team with the appointment of experienced Relationship Manager Sarah MacInnes, strengthening client support and risk management capacity.

Time Finance targets seasonal cash flow pressure with flexible funding

Time Finance is highlighting flexible repayment structures as a way for seasonal businesses to invest at the right time while protecting working capital.

Time Finance publishes Scheme Document for Bentley Park acquisition

Time Finance has published the Scheme Document for its recommended cash acquisition by Bentley Park, with shareholder meetings scheduled for 1 October 2026 and completion expected in Q4 2026.

Time Finance targets working capital gap as late-payment rules tighten

Time Finance is positioning Invoice Finance as a practical response to the working capital pressure created by late payments while new SME protections move forward.

Time Finance highlights SME funding as Labour sets new economic priorities

Time Finance highlights the importance of SME funding, policy stability and business confidence as Labour’s new leadership begins to shape its economic priorities.

Bentley Park agrees £55.1m cash acquisition of Time Finance

Bentley Park, parent company of Ultimate Finance, has agreed a recommended 59.1p-per-share cash offer for Time Finance, valuing the specialist lender at approximately £55.1 million. The deal is expected to complete in the fourth quarter of 2026, subject to shareholder, court and regulatory approvals.

Search